RxDoctor Payments Data

Jared Gremillion, DPM

Podiatrist · Bristol, TNNPI 1639526577

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (49.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Arthrex at 43.3% of the total. Reporting peaked in 2019 at $4,523 and has fallen 63.7% since, to $1,640 in 2025.

$9,949in general payments, 2019–2025

Across 103 payments — averaging $96.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Smoky Mountain Surgical LLC$2K
  • Alpha Orthopedic Systems$2K
  • Medical Device Business Services, Inc.$310
  • Organogenesis Inc.$177
  • AbbVie$170
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$2,86329%
  • Food & beverage$2,19322%
  • Education$4,89349%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,949 in reported general payments places this provider in the 85th percentile of 105 podiatrist providers in Tennessee.

See all podiatrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$101,491
Medicare patients
428
Services billed
1,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium105$1,353
Ketoconazole63$1,169
Ciclopirox33$800
Clobetasol Propionate12$743
Terbinafine Hcl29$589
Doxycycline Hyclate38$513
Methylprednisolone31$209
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$185

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →